Potent miRNA-128 downregulation in lung cancer patients correlates with tumor differentiation, pathological changes, and metastasis through the targeting of the P13K, ATK, and p38 signaling pathways (Jiang et al., 2016; Hu et al., 2014). This evidence concerns the gene BTK and lung cancer.